Comparative characteristics of the cellular immune response to SARS-CoV-2 during infection and post-vaccination

Comparative characteristics of the cellular immune response to SARS-CoV-2 during infection and post-vaccination

An important area of research concerns monitoring of immune response features in patients with SARS-CoV-2 infection as well as their analysis, as compared with characteristics of vaccine-mediated protection, in order to specify the determinants of cellular immune response. The aim of our work was to...

Full description

Bibliographic Details
Main Authors:	S. N. Klyueva, S. A. Bugorkova, A. L. Kravtsov, T. N. Kashtanova, V. A. Kozhevnikov
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2024-01-01
Series:	Медицинская иммунология
Subjects:	covid-19 sars-cov-2 s protein peptide vaccine memory t cells cytokines
Online Access:	https://www.mimmun.ru/mimmun/article/view/2690

Similar Items

Morphofunctional characteristics of blood cells in reconvalescents after suffering COVID-19
by: S. N. Klyueva, et al.
Published: (2022-07-01)

Identifying correlates of protection from <i>Yersinia pestis</i> on a mouse model and assessing an opportunity for their use as markers of human vaccination efficiency
by: Svetlana N. Klyueva, et al.
Published: (2022-05-01)

Complex analysis of correlation interrelations between indicators of humoral and cellular immunity in persons vaccinated against plague
by: S. N. Klyueva, et al.
Published: (2019-05-01)

The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines
by: Zhongjie Sun, et al.
Published: (2022-07-01)

Humoral and cellular immunity in three different types of COVID-19 vaccines against SARS-CoV-2 variants in a real-world data analysis
by: Ying-Chyi Song, et al.
Published: (2023-08-01)

Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
by: Pankaj Ahluwalia, et al.
Published: (2021-05-01)

Humoral and cellular immune responses against SARS-CoV-2 post-vaccination in immunocompetent and immunocompromised cancer populations
by: Elizabeth Titova, et al.
Published: (2024-03-01)

The BNT162b2 vaccine induces humoral and cellular immune memory to SARS-CoV-2 Wuhan strain and the Omicron variant in children 5 to 11 years of age
by: Bianca Laura Cinicola, et al.
Published: (2022-12-01)

Immunoinformatics based prediction of recombinant multi-epitope vaccine for the control and prevention of SARS-CoV-2
by: Muhammad Asif Rasheed, et al.
Published: (2021-06-01)

Antibody and Memory B-Cell Immunity in a Heterogeneously SARS-CoV-2-Infected and -Vaccinated Population
by: Eva Bednarski, et al.
Published: (2022-08-01)

Increased expression of tyrosine protein phosphatase (CD45) on the surface of human blood granulocytes under the influence of the plague microbe vaccine strain <I>Yersinia pestis</I> EV NIIEG <I>ex vivo</I> and <I>in vivo</I>
by: A. L. Kravtsov, et al.
Published: (2024-01-01)

Metabolomics-based investigation of SARS-CoV-2 vaccination (Sinovac) reveals an immune-dependent metabolite biomarker
by: Maozhang He, et al.
Published: (2022-09-01)

Multi-Epitope Vaccine Design Using an Immunoinformatic Approach for SARS-CoV-2
by: Ye Feng, et al.
Published: (2021-06-01)

Cytokines and Chemokines in Breastmilk of SARS-CoV-2 Infected or COVID-19 Vaccinated Mothers
by: Felicia Trofin, et al.
Published: (2022-11-01)

Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2
by: Nikola Hudakova, et al.
Published: (2021-05-01)

The protective immunity induced by SARS-CoV-2 infection and vaccination: a critical appraisal
by: Eduardo Tosta
Published: (2021-08-01)

Immune Response to SARS-CoV-2 Vaccines
by: Navya Bellamkonda, et al.
Published: (2022-06-01)

Proteomic Analysis of Mucosal and Systemic Responses to SARS-CoV-2 Antigen
by: Neil Martinson, et al.
Published: (2023-02-01)

Immunological and Clinical Aspects of Immune Responses to SARS-CoV-2
by: Ali Reza Andalib, et al.
Published: (2021-03-01)

Humoral immunity for durable control of SARS-CoV-2 and its variants
by: Ryutaro Kotaki, et al.
Published: (2023-01-01)

The impact of Immunomodulators on Reactivity the immune System cells in Model Vaccinal process against Tularemia
by: A. L. Kravtsov, et al.
Published: (2016-06-01)

SARS-CoV-2 mRNA Vaccine-Induced Cellular and Humoral Immunity in Hemodialysis Patients
by: Ewa Kwiatkowska, et al.
Published: (2022-03-01)

Evaluation of post-vaccination immunoglobulin G antibodies and T-cell immune response after inoculation with different types and doses of SARS-CoV-2 vaccines: A retrospective cohort study
by: Rami H. Al-Rifai, et al.
Published: (2023-01-01)

Post-vaccination reactions occurring in patients vaccinated against SARS-COV-2
by: Izabela Wróblewska, et al.
Published: (2021-12-01)

A Glimpse into the Diverse Cellular Immunity against SARS-CoV-2
by: Cheng-Wei Chang, et al.
Published: (2021-07-01)

Comparison of the Development of SARS-Coronavirus-2-Specific Cellular Immunity, and Central Memory CD4+ T-Cell Responses Following Infection versus Vaccination
by: Kevin M. Dennehy, et al.
Published: (2021-12-01)

Waning immunity to SARS-CoV-2 following vaccination or infection
by: Carlos Hernandez-Suarez, et al.
Published: (2022-10-01)

Role of the cellular immunity in the formation of the immune response in coronavirus infections
by: I. A. Ivanova, et al.
Published: (2021-12-01)

Study of the cellular and humoral immune responses to SARS-CoV-2 vaccination
by: Faustine Montmaneix-Engels, et al.
Published: (2024-04-01)

Transient akathisia after the SARS-Cov-2 vaccine
by: Meagen R. Salinas, et al.
Published: (2021-01-01)

Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1
by: Khalid A. Alluhaybi, et al.
Published: (2021-08-01)

Dynamics of humoral immunity during natural infection with SARS-CoV-2 and/or after vaccination with the Sputnik V vaccine
by: Марина Александровна Уварова, et al.
Published: (2019-08-01)

Determine the Potential Epitope Based Peptide Vaccine Against Novel SARS-CoV-2 Targeting Structural Proteins Using Immunoinformatics Approaches
by: Muhammad Waqas, et al.
Published: (2020-10-01)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
by: Krystallenia Paniskaki, et al.
Published: (2022-10-01)

Immunological Analysis of People in Northeast China after SARS-CoV-2 Inactivated Vaccine Injection
by: Yu Fu, et al.
Published: (2021-09-01)

Lymphocyte Subpopulations Associated with Neutralizing Antibody Levels of SARS-CoV-2 for COVID-19 Vaccination
by: Wan-Ting Huang, et al.
Published: (2022-09-01)

CXCL12 and CXCL13 Cytokine Serum Levels Are Associated with the Magnitude and the Quality of SARS-CoV-2 Humoral Responses
by: Alessandra Noto, et al.
Published: (2022-11-01)

Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon Ex Vivo Restimulation
by: Maria G. Byazrova, et al.
Published: (2022-02-01)

Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2)
by: Rajesh Anand, et al.
Published: (2020-09-01)

Immune responses in SARS-CoV-2, SARS-CoV, and MERS-CoV infections: A comparative review
by: Soussan Irani
Published: (2022-01-01)